RejuvenRx Inc. is an emerging biotech company located in Montreal, QC, aiming to develop new therapeutics for aging and cancers that focus on stem cell biology. Supported by an innovative platform identifying stem cell therapeutic targets, the company is building a pipeline of transformative drug discovery programs. These programs are intended to use molecular glue modalities and conventional inhibition methods to potentially enhance patient health and longevity.